CardioRisk nd 23 rd November 2017 The Egyptian Association of Vascular Biology and Atherosclerosis الجمعية المصرية لتصلب شرايين القلب

Size: px

Start display at page:

Download "CardioRisk nd 23 rd November 2017 The Egyptian Association of Vascular Biology and Atherosclerosis الجمعية المصرية لتصلب شرايين القلب"

Damian Clarke
6 years ago
Views:

1 CardioRisk 2017 22 nd 23 rd November 2017 The Egyptian Association of

1 1 CardioRisk nd 23 rd November 2017 The Egyptian Association of Vascular Biology and Atherosclerosis الجمعية المصرية لتصلب شرايين القلب Endorsed By

2 2 Contents Welcome Note About EAVA & CardioRisk EAVA Board Internationa Guests Speakers Organizational Notes Audiovisual Instructions Acknowledgement Scientific Program

3 3 On behalf of the Egyptian Association of Vascular biology & Atherosclerosis (EAVA) and CardioRisk scientific board, Let me welcome you all in CardioRisk 2017 that will be held in Hurghada Egypt November The meeting this year will not only cover lipidology science but, in addition, will extend to cover many subjects related to CV risk factors especially hypertension and DM with eminent faculty. Looking forward to seeing you all, and let me wish you an enjoyable and fruitful meeting. Ashraf Reda, MD, FESC President of EAVA

4 4 About EAVA & CardioRisk CardioRisk CME activities started 2011, with a series of accredited educational meetings all over Egypt discussing assessment and management of cardiovascular risk in view of the different national and international guidelines. The meeting this year will celebrate the fiundation of the familial hypercholesterolemia research forum (FHRF) in Egypt and the initiation of FH observational study in collaboration with the European Atherosclerosis Society In addition to the cyclic CME activities, the annual congress and the ongoing Egyptian risk factor and lipid project, EAVA is initiating the CardioRisk research project including a national observational study and a promoting program supporting researches addressing cardiovascular risk and preventive strategies in the community. CardioRisk 2017 scientific program will cover the recent updates in atherosclerosis, vascular biology and cardiovascular prevention by eminent speakers. CardioRisk scientific committee has the pleasure to invite you to participate and share with us the science of CardioRisk 2017 as well as the beauty of Hurghada, Egypt.

5 EAVA Board 5 Atef Elbahry Ahmed Shawky Founding President Ashraf Reda Vice Presidents Secretary General Elsayed Farag As. Secretary Nabil Farag Ahmed Elkersh Executive Board Ihab Atia Osama Sanad Sameh Salama Hazem Khamis Hany Ragy Amr Kamal Tamer Moustafa Ahmed Boghdady Office Board Ashraf Reda Mourad Beshay Ahmed Elkersh Awny Gamal

6 6 International Guests Speakers Andreas Zirlik - Germany Prof. Dr. Andreas Zirlik is Deputy Medical Director of the Department of Cardiology and Angiology I of the Heart Center of Freiburg University in Germany. He practices interventional cardiology and interventional hypertensiology and heads the heart failure and heart transplantation service. He also leads a research laboratory with a major interest in inflammatory mechanisms in atherogenesis and at the interface of cardiovascular, metabolic disease, and thrombosis. Gerald Tomkin - Ireland Gerald Tomkin was born in Dublin Ireland and studied Medicine in Trinity College Dulin. He continued his post graduate trainijng in the UK and the USA before returning to take up a position as a consultant physician/endocrinologist in the Adelaide and Meath Hospitals/Trinity College. His Research interests have focussed on diabetes, dyslipidaemiaand obesity. He is past vice president of the European Association for the study of diabetes, past president of Association of Physicians of Great Britain and Ireland and is currentlypresident of Diabetes Ireland.

Michal Vrablik - Czech Republic Michal Vrablik M.D., Ph.D. is currently an Associate Professor of Internal Medicine at the 1st Faculty of Medicine, Charles University in Prague, the Czech Republic.

7 Michal Vrablik - Czech Republic Michal Vrablik M.D., Ph.D. is currently an Associate Professor of Internal Medicine at the 1st Faculty of Medicine, Charles University in Prague, the Czech Republic. He is the chairman of the Czech Atherosclerosis Society, served as a member of the Executive Committee of the European Atherosclerosis Society between 2012 and 2016 and, also, a member of the board of the Czech Society of Internal Medicine and the board of the Working group of preventive cardiology of the Czech Society of Cardiology. 7 Stephan Von Haehling - UK Stephan Von Haehling is a consultant cardiologist and Associate Professor of Medicine at the Department of Cardiology and Pneumology at the University Medical Center Göttingen, Germany. He obtained his MD at the Institute of Immunology at Charité Medical School, Berlin, Germany. His PhD was awarded by Imperial College, London, UK after he completed studies into inflammatory mechanisms of heart failure at the National Heart and Lung Institute in London. Dr. von Haehling has authored more than 200 original research papers, review articles, and editorials and serves on several editorial boards, including Journal of Cachexia, Sarcopenia and Muscle, ESC Heart Failure, International Journal of Cardiology, Clinical Science, Expert Opinion on Investigational Drugs and Archives of Medical Science. Dr von Haehling is Fellow of the European Society of Cardiology. His research interests include the pathophysiology of heart failure, muscle wasting, biomarkers, and novel treatments.

8 8

9 9 Conference Venue Mövenpick Hurghada is located, nestled in Hurghada Bay, directly on its own beach and with private access to the Red Sea. Only a ten-minute drive from Hurghada International Airport and a few minutes from the city center. The Mövenpick Hurghada is nestled in Hurghada Bay, at the Southern end of town, directly on the famous promenade, a pedestrian road, locally known as the Mamsha. Housing All rooms are on half Board Basis at Movenpick Hotel Hilton Hotel Marriott Hotel Grand Plaza Hotel Lunch is only served upon coupons at Mövenpick Hotel

10 10 Language The official language is English There will be no translation available Weather Forecast High: 35 / Low: 21 Electricity The electricity supply in Egypt is 220 Volts, 50 Hz. Most hotels also provide 110 Volts outlets for shavers Currency Banking Rates are subjects to market fluctuations Registration desk will be ready on Wednesday 22 nd of November at 14:30 Registration desk will be ready on Thursday, 23 rd of November at 15:00 Registration desk will be ready on Friday, 24 th of November at 15:30 Badge All registrants and exhibitors must wear their name badge to have access to Conference sessions, lunches and social events. No exceptions will be made Website

All refreshments and Coffee Breaks activities will be

Each coupon is valid only for the meal mentioned on it

Coffee Breaks for Chairpersons and Speakers will be

11 All refreshments and Coffee Breaks activities will be served against coupon in the Conference kit. Each coupon is valid only for the meal mentioned on it and according to the timing mentioned below with no stop of the scientific program. Coffee Breaks will be available at Exhibition Area 11 Coffee Breaks for Chairpersons and Speakers will be available at The Faculty Lounge Wednesday at 21:40 Dinner Thursday at 22:10 Friday at 22:00

12 12 Audiovisual Instructions Dear Speaker, You will soon be presenting at CardioRisk Conference and we want this experience to go as smoothly as possible for you. On behalf of CardioRisk conference, ICOM will manage the audiovisual center and provide you with assistance before, during and after your presentation. * Please make sure that you received your personal program (by e- mail), we also advise that you check the final program available online. * All speakers are required to submit their presentations at the audiovisual center. * Please make sure that you keep a copy of your presentation for backup. For Case Presentations All case presentations should be submitted at least 24 hours prior to the session Submitting your Presentation All presentations should be entirely in English. Microsoft Power Point, Apple Keynote and Prezi presentations are supported. Please submit your presentation on Flash Memory or CD/DVD. Please make sure that the presentation contains all media and video files included in your presentation. It s not allowed to use your personal laptop. Presentations should be submitted to the audiovisual center at least one hour before the start of your session to be able to prepare it. Inside The Hall Please arrive at the Congress main hall at least 10 minutes prior to the beginning of your session. Thank you for abiding by the allocated duration of your presentation. A computerized countdown timer will be displayed on screen and will automatically close the presentation once the time is finished

13 Acknowledgement CardioRisk 2017 Expresses great gratitude to the following companies sharing in the activities and success of the conference 13 Platinum Sponsors Gold Sponsors Silver Sponsors

14 Other Sponsors 14

15 15

16 16 At Glance Wednesday 22 nd November :00 16:45 Session 1 Dialogue I - Obesity 16:50 17:20 Session 2 Debate I - Statin and Diabetes 17:25 18:25 Session 3 EAVA Rising Stars I - Case Dialogue 18:30 19:00 Session 4 Debate II - Dietary Fat a Friend or an Enemy? 19:00 19:15 Coffee Break 19:15 20:05 Session 5 Dialogue II - Dealing With The Elderly 20:10 20:55 Session 6 Plenary I - The Issue of Hypertriglyceridemia 21:00 21:40 Sanofi Symposium 21:40 Dinner Grant from Sanofi

17 Hall: Main - 16:00-16:45 Commentators (in Alphabetical Order) Ahmed El Ghalid - Suez Canal Mohamed Abdelshafy Banha Discussants (in Alphabetical Order) El Sayed Farag Zagazig Gehan Fouad Cairo Moderator Atef Elbahry - Port Said Session 1 Dialogue I Obesity Amr Kamal - Alexandria Sharaf Ashazly - Sohag Enas Shaltout - Cairo 17 16:00-16:10 Introductions and questions to the panellists: Obesity is a chronic disease Atef Elbahry Port Said 16:10-16:15 Answer Q1: Barriers in clinical practice facing obesity Enas Shaltout 16:15-16:20 Discussion 16:20-16:25 Answer Q2: The obesity paradox El Sayed Farag 16:25-16:30 Discussion 16:30-16:40 Answer Q4: Nutritional aspects Gehan Fouad 16:40-16:45 Discussion Cairo Zagazig Cairo

18 18 Hall: Main - 16:50-17:20 Chairpersons (in Alphabetical Order) Ahmed El Kersh - Menoufia Mahmoud Soliman - Menoufia Session 2 Debate I Statin and Diabetes El Sayed Abdel Khalek - Banha Tarek Naguib - Zagazig 16:50-17:02 Statin and Diabetes Pro Mohamed Seleem 17:02-17:14 Contra Ahmed Shawky 17:14-17:20 Discussion NHI Ain Shams

19 Hall: Main - 17:25-18:25 Discussants (in Alphabetical Order) Ahmad Boghday - Sohag Ashraf Reda - Menoufia Moderator El Sayed Farag - Zagazig Session 3 EAVA Rising Stars I Case Dialogue Ahmed El Zaiaat - Zagazig Mohamed Seleem - NHI 19 17:25-17:35 2ry Hypertension case Zagazig Team Ahmed Eraky Ayman Naguib 17:35-17:45 Comments and discussion 17:45-17:55 Familial Dyslipidemia Ain Shams Team Amr Gamal Shawky Shehab El Etriby 17:55-18:05 Comments and discussion 18:05-18:15 Diabetic nephropathy Alexandria Team Ahmed Yehia Ashraf Elamin 18:15-18:25 Comments and discussion Zagazig Zagazig Ain Shams Ain Shams Alexandria Alexandria

20 20 Hall: Main - 18:30-19:00 Chairpersons (in Alphabetical Order) Hazem Khamis - Six October Morad Beshay - Menoufia Moderator Ihab Attia - Ain Shams Session 4 Debate II Dietary Fat a Friend or an Enemy? Mahmoud Kamel - Menoufia 18:30-18:42 Does dietary Fat increase CV risk? NO Nabil Farag 18:42-18:54 YES Ashraf Reda 18:54-19:00 Discussion Ain Shams Menoufia Coffee Break 19:00 19:15

21 Hall: Main - 19:15-20:05 Commentators (in Alphabetical Order) Awny Gamal Menoufia Nabil Farag - Ain Shams Discussants (in Alphabetical Order) Amr Kamal - Alexandria Ihab Attia - Ain Shams Moderator Hazem Khamis - Six October Session 5 Dialogue II Dealing With The Elderly El Sayed Farag - Zagazig Enas Shaltout - Cairo Tamer Moustafa - Zagazig 21 19:15-19:25 Introductions and questions to the panellists Hazem Khamis 19:25-19:30 Answer Q1: The elderly with hypertension Tamer Moustafa 19:30-19:35 Discussion 19:35-19:40 Answer Q2: The elderly with diabetes Enas Shaltout 19:40-19:45 Discussion 19:45-19:50 Answer Q3: The elderly with Dyslipidemia Ihab Attia 19:50-19:55 Discussion 19:55-20:00 Answer Q4: The elderly with ACS Amr Kamal 20:00-20:05 Discussion Six October Zagazig Cairo Ain Shams Alexandria

22 22 Hall: Main - 20:10-20:55 Chairpersons (in Alphabetical Order) Ahmad Boghday Sohag Nevine Samy Menoufia Moderator Ashraf Reda - Menoufia Session 6 Plenary I The Issue of Hypertriglyceridemia Ihab Attia - Ain Shams Walid Abdou - Menoufia 20:10-20:22 Metabolic pathway Ahmed Shawky 20:22-20:25 Discussion 20:25-20:37 Relation to CV events Hassan Khaled 20:37-20:40 Discussion 20:40-20:52 Treatment algorithm Tamer Moustafa 20:52-20:55 Discussion Ain Shams Cairo Zagazig

Hall: Main - 21:00-21:40 Chairpersons (in Alphabetical Order) Ahmed Fathy - NHI Ihab Attia - Ain Shams Sanofi Symposium Ashraf Reda - Menoufia Nabil Farag - Ain Shams 23 21:00-21:15 Comprehensive

23 Hall: Main - 21:00-21:40 Chairpersons (in Alphabetical Order) Ahmed Fathy - NHI Ihab Attia - Ain Shams Sanofi Symposium Ashraf Reda - Menoufia Nabil Farag - Ain Shams 23 21:00-21:15 Comprehensive Cardiovascular Protection Beyond BP Control Waleed ElAwady 21:15-21:20 Discussion 21:20-21:35 ACS and beyond: Role of antiplatelets in polyvascular patient Tamer Moustafa 21:35-21:40 Discussion and Closing Remarks Zagazig Zagazig Day 1 Group Photo Dinner 21:40

24 24 At Glance Thursday 23 rd November :00 15:00 Cath Competition Bifurcation, Complex PCI and others 16:00 17:00 Session 7 Diabetes I - Is Cardiovascular Protection at Long Last a Reality? 17:05 17:50 Session 8 Dialogue III - Genetic Studies and CV Protection Session 9 17:55 18:55 Joint Session Between the Egyptian (EAVA) and German (DGAF) Atherosclerosis Societies The Future of Cardiovascular Risk Management Targeting Inflammation or Targeting Lipid 18:15-18:45 Coffee Break 19:00 19:45 Novartis Symposium Heart Failure :50 20:40 Session 10 Planery II - The Guidelines: What Happened? 20:45 21:35 Session 11 Game Changing Trials I 21:40 22:10 Sanofi Symposium 22:10 Dinner

25 Hall: Main - 12:00-15:00 Moderators (in Alphabetical Order) Adel El Etriby - Ain Shams Hamdy Soliman - NHI Nabil Farag - Ain Shams Cath Competition Bifurcation, Complex PCI and others Amr El Hadidy - Cairo M Fareed Elguindy - NHI 25

26 26 Hall: Main - 16:00-17:00 Chairpersons (in Alphabetical Order) Adel El Etriby - Ain Shams Enas Shaltout Cairo Noshy Youssef - Ain Shams Moderator Atef Elbahry - Port Said Session 7 Diabetes I Is Cardiovascular Protection at Long Last a Reality? Alaa Medhat - Cairo Hesham Rashid - Banha Tarek Zaky - Ain Shams 16:00-16:10 The cardiologist review Atef Elbahry 16:10-16:13 Discussion 16:13-16:23 Update in hypertension management in the diabetic El Sayed Farag 16:23-16:26 Discussion 16:26-16:40 Update in lipid management in the diabetic Mohamed Abdelghany 16:40-16:45 Discussion 16:45-17:00 Diabetes, Dyslipidemia and atherosclerosis Gerald Tomkin Port Said Zagazig Cairo Ireland

27 Hall: Main - 17:05-17:50 Commentators (in Alphabetical Order) Gamal Shaaban NHI Hany Ragy NHI Khaled Leon NHI Discussants (in Alphabetical Order) Ahmed Shawky - Ain Shams Ihab Attia - Ain Shams Moderator Ashraf Reda - Menoufia Session 8 Dialogue III Genetic Studies and CV Protection Ghada Kazamel - NHI Khairy Abdel Dayem - Ain Shams Ragab Abdelsalam - Zagazig Amal Rizk - Cairo Karim Mahmoud Abdel Hamid - Cairo 27 17:05-17:10 Introduction and questions Ashraf Reda 17:10-17:15 Answer Q1: The earlier the better Ihab Attia 17:15-17:20 Discussion 17:20-17:25 Answer Q2: Diagnosis of Familial hypercholesterolemia Ahmed Shawky 17:25-17:30 Discussion 17:30-17:35 Answer Q3: Value of Mandelian randomisation studies Karim Mahmoud Abdel Hamid 17:35-17:40 Discussion 17:40-17:45 Answer Q 4: Genetic screening for whom Amal Rizk 17:45-17:50 Discussion Menoufia Ain Shams Ain Shams Cairo Cairo

28 28 Hall: Main - 17:55-18:55 Session 9 Joint Session Between the Egyptian (EAVA) and German (DGAF) Atherosclerosis Societies The Future of Cardiovascular Risk Management Targeting Inflammation or Targeting Lipid Chairpersons (in Alphabetical Order) Ahmed Shawky - Ain Shams El Sayed Farag - Zagazig Hazem Khamis - Six October Nabil Farag - Ain Shams Ossama Sanad - Banha 17:55-18:07 Anti-inflammatory therapy of Atherosclerosis - CANTOS from hope to reality Andreas Zirlik Germany 18:07-18:10 Discussion 18:10-18:22 LDL cholesterol - Far more than a simple risk factor Ashraf Reda 18:22-18:25 Discussion Menoufia 18:25-18:37 Modern lipid management in the era of PCSK9 inhibition - How low should we go? Atef Elbahry Port Said 18:37-18:40 Discussion 18:40-18:52 Balancing residual inflammatory and residual risk: An outlook Andreas Zirlik Germany 18:52-18:55 Discussion Group photo for the first German/ Egyptian Atherosclerosis CME activity Coffee Break 18:15 18:45

29 Hall: Main - 19:00-19:45 Chairpersons (in Alphabetical Order) Alaa Etman - NHI Hossam Kandil - Cairo Magdy Abdel Hamid - Cairo Novartis Symposium Heart Failure 2017 Diaa El Menshawy - zagazig Khalid Shokry - Military Academy 29 19:00-19:12 ARNi & Guidelines of heart failure Ashraf Reda 19:12-19:15 Discussion 19:15-19:27 Quality of life in heart failure does ARNi change it Atef Elbahry 19:27-19:30 Discussion 19:30-19:42 Heart Failure & hospitalization Sameh Emil 19:42-19:45 Discussion Menoufia Port Said Military Academy

30 30 Hall: Main - 19:50-20:40 Chairpersons (in Alphabetical Order) Amin Fouad - Military Academy Ayman Aboul Magd - Al Azhar Sameh Emil - Military Academy Session 10 Planery II The Guidelines: What Happened? Amr El Hadidy - Cairo Mohamed Sobhy - Alexandria 19:50-20:02 STEMI guidelines Hesham Salah El Din 20:02-20:05 Discussion 20:05-20:20 Recent development of HF 2016 guidelines Stephan Von Haehling 20:20-20:25 Discussion 20:25-20:37 P2y12 inhibitors guidelines in ACS +AF Dual or triple Mohamed Seleem 20:37-20:40 Discussion Cairo Germany NHI

31 Hall: Main - 20:45-21:35 Chairpersons (in Alphabetical Order) Ahmed Magdy NHI Hesham Aboul Einen Banha Tarek Abdel Ghaffar NHI Moderator Tamer Moustafa - Zagazig Session 11 Game Changing Trials I Alaa Elghamrawy - El Mahala Ramzy Elmawardy - Ain Shams 31 20:45-20:57 EMPA-REG OUTCOME Ihab Attia 20:57-21:00 Discussion Ain Shams 21:00-21:15 The REVEAL (Randomized EValuation of the Effects of Anacetrapib through Lipid modification) Andreas Zirlik Germany 21:15-21:20 Discussion 21:20-21:32 PARADIGM HF trial Magdy Abdel Hamid 21:32-21:35 Discussion Cairo

32 32 Hall: Main - 21:40-22:10 Chairpersons (in Alphabetical Order) Abdulla Moustafa - Menoufia Amr El Hadidy - Cairo Fayez Fayek - NHI Magdy Mattar - Alexandria Sanofi Symposium Aly Saad - Zagazig Ezz El Din El Sawy - Al Azhar Gamal Fahim - Mansoura 21:40-22:00 Current status and future prospect in dyslipidaemia management Ashraf Reda 22:00-22:10 Discussion Menoufia Day 2 Group Photo Dinner 22:10

33 33 At Glance Thursday 23 rd November :30 16:15 Session 12 EAVA Rising Stars II Session 13 16:30 17:15 Dialogue Room IV - Hypertension Masked, White Coat or Something Else? Hypertension Issues 17:25 18:05 Session 14 Plenary III - The CV Continuum and Novel Therapeutics 18:10 18:40 AstraZeneca Symposium 18:45 19:15 Coffee Break 18:45 19:45 Session 15 Plenary IV - Questions in Dyslipidaemia Management 19:50 20:40 Session 16 Game Changing Trials II 20:40 21:10 Servier Symposium 21:10 22:05 Session 17 Plenery V - Smoking in Egypt : What To Do? 22:05 Dinner

34 34 Hall: Main - 15:30-16:15 Discussants (in Alphabetical Order) Ahmed Shawky - Ain Shams Mohamed Abdelshafy - Banha Sharaf Ashazly - Sohag Yasser Huzayen - Ain Shams Moderator El Sayed Farag - Zagazig Session 12 EAVA Rising Stars II Karim Mahmoud Abdel Hamid - Cairo Moustafa Mokarab - Al Azhar Waleed Ammar - Cairo EAVA mini quiz (Education by Competition)

35 Hall: Main - 16:30-17:15 Session 13 Dialogue Room IV Hypertension Masked, White Coat or Something Else? Hypertension Issues Commentators (in Alphabetical Order) Ahmed Abdellatif Ramadan - Al Azhar Aly Kasem - Sohag Khaled El Rabbat Banha Moustafa Elsayed - Al Azhar Saeid Shalaby Menoufia Yasser Abdelhady - Discussants (in Alphabetical Order) Amr El Hadidy - Cairo Ramzy Elmawardy - Ain Shams Moderator Ashraf Reda - Menoufia Hossam Kandil - Cairo 35 16:30-16:40 Introduction and questions Ashraf Reda 16:40-16:45 Answer to Q1 - White coat hypertension, is it really matter? Ramzy Elmawardy 16:45-16:50 Discussion 16:50-17:00 Answer Q2: Dipper/ non-dipper and CV risk Amr El Hadidy 17:00-17:05 Discussion 17:05-17:10 Answer Q3: Masked hypertension Hossam Kandil 17:10-17:15 Discussion Menoufia Ain Shams Cairo Cairo

36 36 Hall: Main - 17:25-18:05 Chairpersons (in Alphabetical Order) Ahmed Wafa - Mansoura Ihab Attia - Ain Shams Ossama Sanad - Banha Session 14 Plenary III The CV Continuum and Novel Therapeutics Ayman Aboul Magd - Al Azhar Mohamed Sobhy - Alexandria 17:25-17:40 Risk stratification 2017 and high CV risk identification Michal Vrablik 17:40-17:45 Discussion 17:45-18:00 New drugs in HF - From omecamtive mecorbil to vericiguard Stephan Von Haehling 18:00-18:05 Discussion Czech Republic Germany

37 Hall: Main - 18:10-18:40 Chairpersons (in Alphabetical Order) Ahmed Yehia Hegab - NHI Magdy El Khadem - NHI Sherif Wagdy Ayad - Alexandria AstraZeneca Symposium Amr El Hadidy - Cairo Mahmoud Hassanein - Alexandria Yehia Kishk - Assiut 37 18:10-18:22 Fresh look on DAPT choice and duration Ramez Guindy 18:22-18:25 Discussion 18:25-18:37 Role of Seloken ZOC in Hypertension and Heart disease Ashraf Reda 18:37-18:40 Discussion Ain Shams Menoufia

38 38 Hall: Main - 18:45-19:45 Chairpersons (in Alphabetical Order) Adel Alam - Al Azhar Ezz El Din El Sawy - Al Azhar Mohamed Gamal - Assiut Session 15 Plenary IV Questions in Dyslipidaemia Management Ahmed Fathy - NHI Islam Shawki - Al Azhar Samia Elkady - NHI 18:45-18:57 LDL cholesterol goal 70 mg/dl? 50 mg/dl? or even less? Nabil Farag 18:57-19:00 Discussion 19:00-19:12 Mandelian Randomisation studies and LDL causality Ahmed Shawky 19:12-19:15 Discussion 19:15-19:27 New therapies in dyslipidemia management Michal Vrablik 19:27-19:30 Discussion Ain Shams Ain Shams Czech Republic 19:30-19:42 Bile, lipid and glucose metabolism between weight reduction and bariatric surgery Gerald Tomkin Ireland 19:42-19:45 Discussion Coffee Break 19:00 19:30

39 Hall: Main - 19:50-20:40 Chairpersons (in Alphabetical Order) Esam Mahfouz - Mansoura Ihab Daoud Hanna - MOH Ramez Guindy - Ain Shams Moderator Tamer Moustafa - Zagazig Session 16 Game Changing Trials II Gamila Mohamed Nasr - Suez Canal Ikram Sadek - Tanta Waleed ElAwady - Zagazig 39 19:50-20:02 COMPASS Hany Ragy 20:02-20:05 Discussion 20:05-20:17 ORBITA Mohammed Hassan 20:17-20:20 Discussion 20:20-20:35 IMPROVE-IT changes the guidlines Atef Elbahry 20:35-20:40 Discussion NHI Cairo Port Said

40 40 Hall: Main - 20:40-21:10 Chairpersons (in Alphabetical Order) Ashraf Reda - Menoufia Samir Rafla - Alexandria Servier Symposium Sameh Emil - Military Academy 20:40-20:52 Use of long acting treatment in hypertension management Ramez Guindy 20:52-20:55 Discussion 20:55-21:07 Listening to ischemic heart needs Amin Fouad 21:07-21:10 Discussion Ain Shams Military Academy

41 Hall: Main - 21:10-22:05 Chairpersons (in Alphabetical Order) Mesbah Taha Hassanein Zagazig Nasser Taha Minia William Moris - Moderator Atef Elbahry - Port Said Session 17 Plenery V Smoking in Egypt : What To Do? Mona Aboul Seoud - Ain Shams Tarek El Khouly - Cairo 41 21:10-21:20 Smoking - The CV burden Atef Elbahry 21:20-21:23 Discussion 21:23-21:33 Smoking in Egyptians with ACS - Data from CardioRisk project Ashraf Reda 21:33-21:36 Discussion 21:36-21:46 What to do Hany Ragy 21:46-21:49 Discussion 21:49-21:59 Smoking in the guidelines Ihab Attia 21:59-22:05 Discussion Port Said Menoufia NHI Ain Shams Day 3 Group Photo Dinner 22:05

Ahmad Al Sarraf Kuwait. Andreas Zirlik Germany

Ahmad Al Sarraf Kuwait. Andreas Zirlik Germany 1 s 2 3 4 5 Ahmad Al Sarraf Kuwait Dr. A Sarraf is the Head of Laboratory department at the Kuwait Cancer Control Center in Kuwait. Dr. Al- Sarraf is member of the Clinical biochemistry committee in Kuwait